Reports

Industry Research Reports

description

Part 1

description

Part 2

description

Part 3

description

Part 4

description

Part 5

Home > Reports > Service & Software > Pharmacokinetics Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Pharmacokinetics Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Pharmacokinetics Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Service & Software

Published: 2026-02-11

Pages: 106 Pages

Report ld: 5951158

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Description

The global market for Pharmacokinetics Software was estimated to be worth US$ 529 million in 2025 and is projected to reach US$ 909 million, growing at a CAGR of 8.2% from 2026 to 2032.

Pharmacokinetics Software is a type of professional software developed based on pharmacokinetic theory and computer algorithms. It is specifically used to process data related to the absorption, distribution, metabolism and excretion of drugs in organisms, and to realize functions such as parameter calculation, model building and process simulation. It provides data support and decision-making basis for drug development, clinical trials and personalized medicine.

Pharmacokinetics Software Market Size(US$)

M= millions and B=billions

QYRLogo
North America still dominates the global market, but the Asia-Pacific market is emerging at a faster growth rate. In 2023, North America was the largest revenue market in the field of pharmacokinetic computational biology, and in the life sciences software market, North America accounted for 42% of the market share in 2024, thanks to its mature innovative drug development system and the strong demand from numerous CRO companies.

Policy adjustments by global regulatory agencies are continuously reshaping the development direction of pharmacokinetic software. The FDA's updated guidance in 2023 explicitly requires innovative drug applications to include physiologically based pharmacokinetic (PBPK) model data, and the EMA plans to implement an electronic submission system for ePK files by 2026. These policies are compelling pharmaceutical companies to adopt software with stronger compliance and better data management capabilities.

This report provides a comprehensive view of the global market for Pharmacokinetics Software, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Pharmacokinetics Software market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Pharmacokinetics Software.

Market Segmentation

  • Report Metric

  • Details

  • Report Title

  • Pharmacokinetics Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

  • Forecasted Market Size in 2032

  • US$ 909 million

  • CAGR(2026-2032)

  • 8.2%

  • Market Size Available for Years

  • 2026-2032

  • Global Pharmacokinetics Software Companies Covered

  • Certara

    Simulations Plus

    IntiQuan GmbH

    Bayer

    Genedata AG

    Thermo Scientific

    SGS

    Pharmaron

    Pumas-AI

    PharmoGo

    Chuangteng Technology

    Medixi Biomedical

  • Global Pharmacokinetics Software Market, by Region

  • North America (U.S., Canada, Mexico)

    Europe (Germany, France, UK, Italy, etc.)

    Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

    South America (Brazil, etc.)

    Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

  • Global Pharmacokinetics Software Market, Segment by Type

  • Compartmental Model

    Non-Compartmental Models

  • Global Pharmacokinetics Software Market, Segment by Application

  • Experimental Design

    Clinical Pharmacokinetics

    Other

  • Product Category

  • Drug Development

    Clinical

    Academic Teaching

  • Market Segment

  • Cloud-Based

    On-premises

  • Forecast Units

  • Million USD

  • Report Coverage

  • Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the Pharmacokinetics Software companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Pharmacokinetics Software revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Pharmacokinetics Software revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 Pharmacokinetics Software Product Introduction
    1.2 Global Pharmacokinetics Software Market Size Forecast (2021–2032)
    1.3 Pharmacokinetics Software Market Trends & Drivers
        1.3.1 Pharmacokinetics Software Industry Trends
        1.3.2 Pharmacokinetics Software Market Drivers & Opportunities
        1.3.3 Pharmacokinetics Software Market Challenges
        1.3.4 Pharmacokinetics Software Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered
2 Competitive Analysis by Company
    2.1 Global Pharmacokinetics Software Players Revenue Ranking (2025)
    2.2 Global Pharmacokinetics Software Revenue by Company (2021–2026)
    2.3 Key Companies’ R&D and Operations Footprint and Headquarters
    2.4 Key Companies Pharmacokinetics Software Product Offerings
    2.5 Key Companies General Availability (GA) Timeline for Pharmacokinetics Software
    2.6 Pharmacokinetics Software Market Competitive Analysis
        2.6.1 Pharmacokinetics Software Market Concentration Rate (2021–2026)
        2.6.2 Top 5 and Top 10 Global Companies by Pharmacokinetics Software Revenue in 2025
        2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pharmacokinetics Software revenue, 2025
    2.7 Mergers & Acquisitions and Expansion
3 Segmentation Pharmacokinetics Software Market Classification
    3.1 Introduction by Type
        3.1.1 Compartmental Model
        3.1.2 Non-Compartmental Models
        3.1.3 Global Pharmacokinetics Software Sales Value by Type
            3.1.3.1 Global Pharmacokinetics Software Sales Value by Type (2021 vs 2025 vs 2032)
            3.1.3.2 Global Pharmacokinetics Software Sales Value, by Type (2021–2032)
            3.1.3.3 Global Pharmacokinetics Software Sales Value, by Type (%), 2021–2032
    3.2 Introduction by Scene
        3.2.1 Drug Development
        3.2.2 Clinical
        3.2.3 Academic Teaching
        3.2.4 Global Pharmacokinetics Software Sales Value by Scene
            3.2.4.1 Global Pharmacokinetics Software Sales Value by Scene (2021 vs 2025 vs 2032)
            3.2.4.2 Global Pharmacokinetics Software Sales Value, by Scene (2021–2032)
            3.2.4.3 Global Pharmacokinetics Software Sales Value, by Scene (%), 2021–2032
    3.3 Introduction by Deployment
        3.3.1 Cloud-Based
        3.3.2 On-premises
        3.3.3 Global Pharmacokinetics Software Sales Value by Deployment
            3.3.3.1 Global Pharmacokinetics Software Sales Value by Deployment (2021 vs 2025 vs 2032)
            3.3.3.2 Global Pharmacokinetics Software Sales Value, by Deployment (2021–2032)
            3.3.3.3 Global Pharmacokinetics Software Sales Value, by Deployment (%), 2021–2032
4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Experimental Design
        4.1.2 Clinical Pharmacokinetics
        4.1.3 Other
    4.2 Global Pharmacokinetics Software Sales Value by Application
        4.2.1 Global Pharmacokinetics Software Sales Value by Application (2021 vs 2025 vs 2032)
        4.2.2 Global Pharmacokinetics Software Sales Value by Application (2021–2032)
        4.2.3 Global Pharmacokinetics Software Sales Value by Application (%), 2021–2032
5 Segmentation by Region
    5.1 Global Pharmacokinetics Software Sales Value by Region
        5.1.1 Global Pharmacokinetics Software Sales Value by Region: 2021 vs 2025 vs 2032
        5.1.2 Global Pharmacokinetics Software Sales Value by Region (2021–2026)
        5.1.3 Global Pharmacokinetics Software Sales Value by Region (2027–2032)
        5.1.4 Global Pharmacokinetics Software Sales Value by Region (%), 2021–2032
    5.2 North America
        5.2.1 North America Pharmacokinetics Software Sales Value, 2021–2032
        5.2.2 North America Pharmacokinetics Software Sales Value by Country (%), 2025 vs 2032
    5.3 Europe
        5.3.1 Europe Pharmacokinetics Software Sales Value, 2021–2032
        5.3.2 Europe Pharmacokinetics Software Sales Value by Country (%), 2025 vs 2032
    5.4 Asia Pacific
        5.4.1 Asia Pacific Pharmacokinetics Software Sales Value, 2021–2032
        5.4.2 Asia Pacific Pharmacokinetics Software Sales Value by Subregion (%), 2025 vs 2032
    5.5 South America
        5.5.1 South America Pharmacokinetics Software Sales Value, 2021–2032
        5.5.2 South America Pharmacokinetics Software Sales Value by Country (%), 2025 vs 2032
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Pharmacokinetics Software Sales Value, 2021–2032
        5.6.2 Middle East & Africa Pharmacokinetics Software Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Pharmacokinetics Software Sales Value Growth Trends, 2021 vs 2025 vs 2032
    6.2 Key Countries/Regions Pharmacokinetics Software Sales Value, 2021–2032
    6.3 United States
        6.3.1 United States Pharmacokinetics Software Sales Value, 2021–2032
        6.3.2 United States Pharmacokinetics Software Sales Value by Type (%), 2025 vs 2032
        6.3.3 United States Pharmacokinetics Software Sales Value by Application, 2025 vs 2032
    6.4 Europe
        6.4.1 Europe Pharmacokinetics Software Sales Value, 2021–2032
        6.4.2 Europe Pharmacokinetics Software Sales Value by Type (%), 2025 vs 2032
        6.4.3 Europe Pharmacokinetics Software Sales Value by Application, 2025 vs 2032
    6.5 China
        6.5.1 China Pharmacokinetics Software Sales Value, 2021–2032
        6.5.2 China Pharmacokinetics Software Sales Value by Type (%), 2025 vs 2032
        6.5.3 China Pharmacokinetics Software Sales Value by Application, 2025 vs 2032
    6.6 Japan
        6.6.1 Japan Pharmacokinetics Software Sales Value, 2021–2032
        6.6.2 Japan Pharmacokinetics Software Sales Value by Type (%), 2025 vs 2032
        6.6.3 Japan Pharmacokinetics Software Sales Value by Application, 2025 vs 2032
    6.7 South Korea
        6.7.1 South Korea Pharmacokinetics Software Sales Value, 2021–2032
        6.7.2 South Korea Pharmacokinetics Software Sales Value by Type (%), 2025 vs 2032
        6.7.3 South Korea Pharmacokinetics Software Sales Value by Application, 2025 vs 2032
    6.8 Southeast Asia
        6.8.1 Southeast Asia Pharmacokinetics Software Sales Value, 2021–2032
        6.8.2 Southeast Asia Pharmacokinetics Software Sales Value by Type (%), 2025 vs 2032
        6.8.3 Southeast Asia Pharmacokinetics Software Sales Value by Application, 2025 vs 2032
    6.9 India
        6.9.1 India Pharmacokinetics Software Sales Value, 2021–2032
        6.9.2 India Pharmacokinetics Software Sales Value by Type (%), 2025 vs 2032
        6.9.3 India Pharmacokinetics Software Sales Value by Application, 2025 vs 2032
7 Company Profiles
    7.1 Certara
        7.1.1 Certara Profile
        7.1.2 Certara Main Business
        7.1.3 Certara Pharmacokinetics Software Products, Services, and Solutions
        7.1.4 Certara Pharmacokinetics Software Revenue (US$ Million), 2021–2026
        7.1.5 Certara Recent Developments
    7.2 Simulations Plus
        7.2.1 Simulations Plus Profile
        7.2.2 Simulations Plus Main Business
        7.2.3 Simulations Plus Pharmacokinetics Software Products, Services, and Solutions
        7.2.4 Simulations Plus Pharmacokinetics Software Revenue (US$ Million), 2021–2026
        7.2.5 Simulations Plus Recent Developments
    7.3 IntiQuan GmbH
        7.3.1 IntiQuan GmbH Profile
        7.3.2 IntiQuan GmbH Main Business
        7.3.3 IntiQuan GmbH Pharmacokinetics Software Products, Services, and Solutions
        7.3.4 IntiQuan GmbH Pharmacokinetics Software Revenue (US$ Million), 2021–2026
        7.3.5 IntiQuan GmbH Recent Developments
    7.4 Bayer
        7.4.1 Bayer Profile
        7.4.2 Bayer Main Business
        7.4.3 Bayer Pharmacokinetics Software Products, Services, and Solutions
        7.4.4 Bayer Pharmacokinetics Software Revenue (US$ Million), 2021–2026
        7.4.5 Bayer Recent Developments
    7.5 Genedata AG
        7.5.1 Genedata AG Profile
        7.5.2 Genedata AG Main Business
        7.5.3 Genedata AG Pharmacokinetics Software Products, Services, and Solutions
        7.5.4 Genedata AG Pharmacokinetics Software Revenue (US$ Million), 2021–2026
        7.5.5 Genedata AG Recent Developments
    7.6 Thermo Scientific
        7.6.1 Thermo Scientific Profile
        7.6.2 Thermo Scientific Main Business
        7.6.3 Thermo Scientific Pharmacokinetics Software Products, Services, and Solutions
        7.6.4 Thermo Scientific Pharmacokinetics Software Revenue (US$ Million), 2021–2026
        7.6.5 Thermo Scientific Recent Developments
    7.7 SGS
        7.7.1 SGS Profile
        7.7.2 SGS Main Business
        7.7.3 SGS Pharmacokinetics Software Products, Services, and Solutions
        7.7.4 SGS Pharmacokinetics Software Revenue (US$ Million), 2021–2026
        7.7.5 SGS Recent Developments
    7.8 Pharmaron
        7.8.1 Pharmaron Profile
        7.8.2 Pharmaron Main Business
        7.8.3 Pharmaron Pharmacokinetics Software Products, Services, and Solutions
        7.8.4 Pharmaron Pharmacokinetics Software Revenue (US$ Million), 2021–2026
        7.8.5 Pharmaron Recent Developments
    7.9 Pumas-AI
        7.9.1 Pumas-AI Profile
        7.9.2 Pumas-AI Main Business
        7.9.3 Pumas-AI Pharmacokinetics Software Products, Services, and Solutions
        7.9.4 Pumas-AI Pharmacokinetics Software Revenue (US$ Million), 2021–2026
        7.9.5 Pumas-AI Recent Developments
    7.10 PharmoGo
        7.10.1 PharmoGo Profile
        7.10.2 PharmoGo Main Business
        7.10.3 PharmoGo Pharmacokinetics Software Products, Services, and Solutions
        7.10.4 PharmoGo Pharmacokinetics Software Revenue (US$ Million), 2021–2026
        7.10.5 PharmoGo Recent Developments
    7.11 Chuangteng Technology
        7.11.1 Chuangteng Technology Profile
        7.11.2 Chuangteng Technology Main Business
        7.11.3 Chuangteng Technology Pharmacokinetics Software Products, Services, and Solutions
        7.11.4 Chuangteng Technology Pharmacokinetics Software Revenue (US$ Million), 2021–2026
        7.11.5 Chuangteng Technology Recent Developments
    7.12 Medixi Biomedical
        7.12.1 Medixi Biomedical Profile
        7.12.2 Medixi Biomedical Main Business
        7.12.3 Medixi Biomedical Pharmacokinetics Software Products, Services, and Solutions
        7.12.4 Medixi Biomedical Pharmacokinetics Software Revenue (US$ Million), 2021–2026
        7.12.5 Medixi Biomedical Recent Developments
8 Industry Chain Analysis
    8.1 Pharmacokinetics Software Value Chain
    8.2 Pharmacokinetics Software Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Key Suppliers of Raw Materials
        8.2.3 Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream (Customer) Analysis
    8.5 Sales Model and Sales Channelss
        8.5.1 Pharmacokinetics Software Sales Model
        8.5.2 Sales Channels
        8.5.3 Pharmacokinetics Software Distributors
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Pharmacokinetics Software Market Trends
 Table 2. Pharmacokinetics Software Market Drivers & Opportunities
 Table 3. Pharmacokinetics Software Market Challenges
 Table 4. Pharmacokinetics Software Market Restraints
 Table 5. Global Pharmacokinetics Software Revenue by Company (US$ Million), 2021–2026
 Table 6. Global Pharmacokinetics Software Revenue Market Share by Company (2021–2026)
 Table 7. Key Companies’ R&D and Operations Footprint and Headquarters
 Table 8. Key Companies Pharmacokinetics Software Product Type
 Table 9. Key Companies General Availability (GA) Timeline for Pharmacokinetics Software
 Table 10. Global Pharmacokinetics Software Companies Market Concentration Ratio (CR5 and HHI)
 Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pharmacokinetics Software revenue, 2025
 Table 12. Mergers & Acquisitions and Expansion Plans
 Table 13. Global Pharmacokinetics Software Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
 Table 14. Global Pharmacokinetics Software Sales Value by Type (US$ Million), 2021–2026
 Table 15. Global Pharmacokinetics Software Sales Value by Type (US$ Million), 2027–2032
 Table 16. Global Pharmacokinetics Software Sales Market Share in Value by Type (2021–2026)
 Table 17. Global Pharmacokinetics Software Sales Market Share in Value by Type (2027–2032)
 Table 18. Global Pharmacokinetics Software Sales Value by Scene: 2021 vs 2025 vs 2032 (US$ Million)
 Table 19. Global Pharmacokinetics Software Sales Value by Scene (US$ Million), 2021–2026
 Table 20. Global Pharmacokinetics Software Sales Value by Scene (US$ Million), 2027–2032
 Table 21. Global Pharmacokinetics Software Sales Market Share in Value by Scene (2021–2026)
 Table 22. Global Pharmacokinetics Software Sales Market Share in Value by Scene (2027–2032)
 Table 23. Global Pharmacokinetics Software Sales Value by Deployment: 2021 vs 2025 vs 2032 (US$ Million)
 Table 24. Global Pharmacokinetics Software Sales Value by Deployment (US$ Million), 2021–2026
 Table 25. Global Pharmacokinetics Software Sales Value by Deployment (US$ Million), 2027–2032
 Table 26. Global Pharmacokinetics Software Sales Market Share in Value by Deployment (2021–2026)
 Table 27. Global Pharmacokinetics Software Sales Market Share in Value by Deployment (2027–2032)
 Table 28. Global Pharmacokinetics Software Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
 Table 29. Global Pharmacokinetics Software Sales Value by Application (US$ Million), 2021–2026
 Table 30. Global Pharmacokinetics Software Sales Value by Application (US$ Million), 2027–2032
 Table 31. Global Pharmacokinetics Software Sales Market Share in Value by Application (2021–2026)
 Table 32. Global Pharmacokinetics Software Sales Market Share in Value by Application (2027–2032)
 Table 33. Global Pharmacokinetics Software Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
 Table 34. Global Pharmacokinetics Software Sales Value by Region (US$ Million), 2021–2026
 Table 35. Global Pharmacokinetics Software Sales Value by Region (US$ Million), 2027–2032
 Table 36. Global Pharmacokinetics Software Sales Value by Region (%), 2021–2026
 Table 37. Global Pharmacokinetics Software Sales Value by Region (%), 2027–2032
 Table 38. Key Countries/Regions Pharmacokinetics Software Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
 Table 39. Key Countries/Regions Pharmacokinetics Software Sales Value, (US$ Million), 2021–2026
 Table 40. Key Countries/Regions Pharmacokinetics Software Sales Value, (US$ Million), 2027–2032
 Table 41. Certara Basic Information List
 Table 42. Certara Description and Business Overview
 Table 43. Certara Pharmacokinetics Software Products, Services, and Solutions
 Table 44. Revenue (US$ Million) in Pharmacokinetics Software Business of Certara (2021–2026)
 Table 45. Certara Recent Developments
 Table 46. Simulations Plus Basic Information List
 Table 47. Simulations Plus Description and Business Overview
 Table 48. Simulations Plus Pharmacokinetics Software Products, Services, and Solutions
 Table 49. Revenue (US$ Million) in Pharmacokinetics Software Business of Simulations Plus (2021–2026)
 Table 50. Simulations Plus Recent Developments
 Table 51. IntiQuan GmbH Basic Information List
 Table 52. IntiQuan GmbH Description and Business Overview
 Table 53. IntiQuan GmbH Pharmacokinetics Software Products, Services, and Solutions
 Table 54. Revenue (US$ Million) in Pharmacokinetics Software Business of IntiQuan GmbH (2021–2026)
 Table 55. IntiQuan GmbH Recent Developments
 Table 56. Bayer Basic Information List
 Table 57. Bayer Description and Business Overview
 Table 58. Bayer Pharmacokinetics Software Products, Services, and Solutions
 Table 59. Revenue (US$ Million) in Pharmacokinetics Software Business of Bayer (2021–2026)
 Table 60. Bayer Recent Developments
 Table 61. Genedata AG Basic Information List
 Table 62. Genedata AG Description and Business Overview
 Table 63. Genedata AG Pharmacokinetics Software Products, Services, and Solutions
 Table 64. Revenue (US$ Million) in Pharmacokinetics Software Business of Genedata AG (2021–2026)
 Table 65. Genedata AG Recent Developments
 Table 66. Thermo Scientific Basic Information List
 Table 67. Thermo Scientific Description and Business Overview
 Table 68. Thermo Scientific Pharmacokinetics Software Products, Services, and Solutions
 Table 69. Revenue (US$ Million) in Pharmacokinetics Software Business of Thermo Scientific (2021–2026)
 Table 70. Thermo Scientific Recent Developments
 Table 71. SGS Basic Information List
 Table 72. SGS Description and Business Overview
 Table 73. SGS Pharmacokinetics Software Products, Services, and Solutions
 Table 74. Revenue (US$ Million) in Pharmacokinetics Software Business of SGS (2021–2026)
 Table 75. SGS Recent Developments
 Table 76. Pharmaron Basic Information List
 Table 77. Pharmaron Description and Business Overview
 Table 78. Pharmaron Pharmacokinetics Software Products, Services, and Solutions
 Table 79. Revenue (US$ Million) in Pharmacokinetics Software Business of Pharmaron (2021–2026)
 Table 80. Pharmaron Recent Developments
 Table 81. Pumas-AI Basic Information List
 Table 82. Pumas-AI Description and Business Overview
 Table 83. Pumas-AI Pharmacokinetics Software Products, Services, and Solutions
 Table 84. Revenue (US$ Million) in Pharmacokinetics Software Business of Pumas-AI (2021–2026)
 Table 85. Pumas-AI Recent Developments
 Table 86. PharmoGo Basic Information List
 Table 87. PharmoGo Description and Business Overview
 Table 88. PharmoGo Pharmacokinetics Software Products, Services, and Solutions
 Table 89. Revenue (US$ Million) in Pharmacokinetics Software Business of PharmoGo (2021–2026)
 Table 90. PharmoGo Recent Developments
 Table 91. Chuangteng Technology Basic Information List
 Table 92. Chuangteng Technology Description and Business Overview
 Table 93. Chuangteng Technology Pharmacokinetics Software Products, Services, and Solutions
 Table 94. Revenue (US$ Million) in Pharmacokinetics Software Business of Chuangteng Technology (2021–2026)
 Table 95. Chuangteng Technology Recent Developments
 Table 96. Medixi Biomedical Basic Information List
 Table 97. Medixi Biomedical Description and Business Overview
 Table 98. Medixi Biomedical Pharmacokinetics Software Products, Services, and Solutions
 Table 99. Revenue (US$ Million) in Pharmacokinetics Software Business of Medixi Biomedical (2021–2026)
 Table 100. Medixi Biomedical Recent Developments
 Table 101. Revenue (US$ Million) in Pharmacokinetics Software Business of Company 40 (2021–2026)
 Table 102. Company 40 Recent Developments
 Table 103. Key Raw Materials Lists
 Table 104. Key Suppliers of Raw Materials Lists
 Table 105. Pharmacokinetics Software Downstream Customers
 Table 106. Pharmacokinetics Software Distributors List
 Table 107. Research Programs/Design for This Report
 Table 108. Key Data Information from Secondary Sources
 Table 109. Key Data Information from Primary Sources


List of Figures
 Figure 1. Pharmacokinetics Software Product Picture
 Figure 2. Global Pharmacokinetics Software Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
 Figure 3. Global Pharmacokinetics Software Sales Value (US$ Million), 2021–2032
 Figure 4. Pharmacokinetics Software Report Years Considered
 Figure 5. Global Pharmacokinetics Software Players Revenue Ranking (US$ Million), 2025
 Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Pharmacokinetics Software Revenue in 2025
 Figure 7. Pharmacokinetics Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 8. Compartmental Model Picture
 Figure 9. Non-Compartmental Models Picture
 Figure 10. Global Pharmacokinetics Software Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Pharmacokinetics Software Sales Value Market Share by Type, 2025 & 2032
 Figure 12. Drug Development Picture
 Figure 13. Clinical Picture
 Figure 14. Academic Teaching Picture
 Figure 15. Global Pharmacokinetics Software Sales Value by Scene (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global Pharmacokinetics Software Sales Value Market Share by Scene, 2025 & 2032
 Figure 17. Cloud-Based Picture
 Figure 18. On-premises Picture
 Figure 19. Global Pharmacokinetics Software Sales Value by Deployment (US$ Million), 2021 vs 2025 vs 2032
 Figure 20. Global Pharmacokinetics Software Sales Value Market Share by Deployment, 2025 & 2032
 Figure 21. Product Picture of Experimental Design
 Figure 22. Product Picture of Clinical Pharmacokinetics
 Figure 23. Product Picture of Other
 Figure 24. Global Pharmacokinetics Software Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
 Figure 25. Global Pharmacokinetics Software Sales Value Market Share by Application, 2025 & 2032
 Figure 26. North America Pharmacokinetics Software Sales Value (US$ Million), 2021–2032
 Figure 27. North America Pharmacokinetics Software Sales Value by Country (%), 2025 vs 2032
 Figure 28. Europe Pharmacokinetics Software Sales Value (US$ Million), 2021–2032
 Figure 29. Europe Pharmacokinetics Software Sales Value by Country (%), 2025 vs 2032
 Figure 30. Asia Pacific Pharmacokinetics Software Sales Value (US$ Million), 2021–2032
 Figure 31. Asia Pacific Pharmacokinetics Software Sales Value by Subregion (%), 2025 vs 2032
 Figure 32. South America Pharmacokinetics Software Sales Value (US$ Million), 2021–2032
 Figure 33. South America Pharmacokinetics Software Sales Value by Country (%), 2025 vs 2032
 Figure 34. Middle East & Africa Pharmacokinetics Software Sales Value (US$ Million), 2021–2032
 Figure 35. Middle East & Africa Pharmacokinetics Software Sales Value by Country (%), 2025 vs 2032
 Figure 36. Key Countries/Regions Pharmacokinetics Software Sales Value (%), 2021–2032
 Figure 37. United States Pharmacokinetics Software Sales Value (US$ Million), 2021–2032
 Figure 38. United States Pharmacokinetics Software Sales Value by Type (%), 2025 vs 2032
 Figure 39. United States Pharmacokinetics Software Sales Value by Application (%), 2025 vs 2032
 Figure 40. Europe Pharmacokinetics Software Sales Value (US$ Million), 2021–2032
 Figure 41. Europe Pharmacokinetics Software Sales Value by Type (%), 2025 vs 2032
 Figure 42. Europe Pharmacokinetics Software Sales Value by Application (%), 2025 vs 2032
 Figure 43. China Pharmacokinetics Software Sales Value (US$ Million), 2021–2032
 Figure 44. China Pharmacokinetics Software Sales Value by Type (%), 2025 vs 2032
 Figure 45. China Pharmacokinetics Software Sales Value by Application (%), 2025 vs 2032
 Figure 46. Japan Pharmacokinetics Software Sales Value (US$ Million), 2021–2032
 Figure 47. Japan Pharmacokinetics Software Sales Value by Type (%), 2025 vs 2032
 Figure 48. Japan Pharmacokinetics Software Sales Value by Application (%), 2025 vs 2032
 Figure 49. South Korea Pharmacokinetics Software Sales Value (US$ Million), 2021–2032
 Figure 50. South Korea Pharmacokinetics Software Sales Value by Type (%), 2025 vs 2032
 Figure 51. South Korea Pharmacokinetics Software Sales Value by Application (%), 2025 vs 2032
 Figure 52. Southeast Asia Pharmacokinetics Software Sales Value (US$ Million), 2021–2032
 Figure 53. Southeast Asia Pharmacokinetics Software Sales Value by Type (%), 2025 vs 2032
 Figure 54. Southeast Asia Pharmacokinetics Software Sales Value by Application (%), 2025 vs 2032
 Figure 55. India Pharmacokinetics Software Sales Value (US$ Million), 2021–2032
 Figure 56. India Pharmacokinetics Software Sales Value by Type (%), 2025 vs 2032
 Figure 57. India Pharmacokinetics Software Sales Value by Application (%), 2025 vs 2032
 Figure 58. Pharmacokinetics Software Value Chain
 Figure 59. Pharmacokinetics Software Cost Structure
 Figure 60. Channels of Distribution (Direct Sales, and Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed

Description

The global market for Pharmacokinetics Software was estimated to be worth US$ 529 million in 2025 and is projected to reach US$ 909 million, growing at a CAGR of 8.2% from 2026 to 2032.

Pharmacokinetics Software is a type of professional software developed based on pharmacokinetic theory and computer algorithms. It is specifically used to process data related to the absorption, distribution, metabolism and excretion of drugs in organisms, and to realize functions such as parameter calculation, model building and process simulation. It provides data support and decision-making basis for drug development, clinical trials and personalized medicine.
North America still dominates the global market, but the Asia-Pacific market is emerging at a faster growth rate. In 2023, North America was the largest revenue market in the field of pharmacokinetic computational biology, and in the life sciences software market, North America accounted for 42% of the market share in 2024, thanks to its mature innovative drug development system and the strong demand from numerous CRO companies.

Policy adjustments by global regulatory agencies are continuously reshaping the development direction of pharmacokinetic software. The FDA's updated guidance in 2023 explicitly requires innovative drug applications to include physiologically based pharmacokinetic (PBPK) model data, and the EMA plans to implement an electronic submission system for ePK files by 2026. These policies are compelling pharmaceutical companies to adopt software with stronger compliance and better data management capabilities.

This report provides a comprehensive view of the global market for Pharmacokinetics Software, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Pharmacokinetics Software market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Pharmacokinetics Software.

Market Segmentation
Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the Pharmacokinetics Software companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Pharmacokinetics Software revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Pharmacokinetics Software revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Related Reports

Pharmacokinetics Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Service & Software

Published: 2026-02-11

Pages: 106 Pages

Report ld: 5951158

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

CHOOSE LICENSE TYPE
tip

USD 3950.00

tip

USD 5925.00

tip

USD 7900.00

Add to Cart

Add to Cart

Buy Now

Buy Now

Have a question?
SIMON LEE

English

English

SIMON LEE

+1-62 6295 2442

Online

JOHN WANG

English

English

JOHN WANG

+41 765 899 438

Offline

HITESH

English

English

HITESH

+91-86 6998 6909

Offline

TANG XIN

Japanese

Japanese

TANG XIN

+81-90 3800 9273

Offline

SUNG-BIN YOON

Korean

Korean

SUNG-BIN YOON

+82-2883 1278

Offline

YUJIE TIAN

English

English

YUJIE TIAN

+86-135-2215-3954

Offline

DAMON

Chinese

Chinese

DAMON

+86-133 1872 9947

Offline

General Email:
global@qyresearch.com
WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 19 years of vast experience

    More than 19 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now